201 related articles for article (PubMed ID: 19934273)
41. Human p57(KIP2) defines a new imprinted domain on chromosome 11p but is not a tumour suppressor gene in Wilms tumour.
Taniguchi T; Okamoto K; Reeve AE
Oncogene; 1997 Mar; 14(10):1201-6. PubMed ID: 9121769
[TBL] [Abstract][Full Text] [Related]
42. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
[TBL] [Abstract][Full Text] [Related]
43. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.
Fornari F; Gramantieri L; Ferracin M; Veronese A; Sabbioni S; Calin GA; Grazi GL; Giovannini C; Croce CM; Bolondi L; Negrini M
Oncogene; 2008 Sep; 27(43):5651-61. PubMed ID: 18521080
[TBL] [Abstract][Full Text] [Related]
44. Regulation of p27
Russo GL; Stampone E; Cervellera C; Borriello A
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32933137
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-21 inhibits p57Kip2 expression in prostate cancer.
Mishra S; Lin CL; Huang TH; Bouamar H; Sun LZ
Mol Cancer; 2014 Sep; 13():212. PubMed ID: 25216674
[TBL] [Abstract][Full Text] [Related]
46. p57(Kip2) knock-in mouse reveals CDK-independent contribution in the development of Beckwith-Wiedemann syndrome.
Duquesnes N; Callot C; Jeannot P; Daburon V; Nakayama KI; Manenti S; Davy A; Besson A
J Pathol; 2016 Jul; 239(3):250-61. PubMed ID: 27015986
[TBL] [Abstract][Full Text] [Related]
47. Cellular Response upon Stress: p57 Contribution to the Final Outcome.
Rossi MN; Antonangeli F
Mediators Inflamm; 2015; 2015():259325. PubMed ID: 26491224
[TBL] [Abstract][Full Text] [Related]
48. Lhx6 and Lhx8 promote palate development through negative regulation of a cell cycle inhibitor gene, p57Kip2.
Cesario JM; Landin Malt A; Deacon LJ; Sandberg M; Vogt D; Tang Z; Zhao Y; Brown S; Rubenstein JL; Jeong J
Hum Mol Genet; 2015 Sep; 24(17):5024-39. PubMed ID: 26071365
[TBL] [Abstract][Full Text] [Related]
49. Investigation of the Effect of Zebularine in Comparison to and in Combination with Trichostatin A on p21Cip1/Waf1/ Sdi1, p27Kip1, p57Kip2, DNA Methyltransferases and Histone Deacetylases in Colon Cancer LS 180 Cell Line.
Sanaei M; Kavoosi F
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1819-1828. PubMed ID: 32592383
[TBL] [Abstract][Full Text] [Related]
50. Distinct developmental roles of cell cycle inhibitors p57Kip2 and p27Kip1 distinguish pituitary progenitor cell cycle exit from cell cycle reentry of differentiated cells.
Bilodeau S; Roussel-Gervais A; Drouin J
Mol Cell Biol; 2009 Apr; 29(7):1895-908. PubMed ID: 19139274
[TBL] [Abstract][Full Text] [Related]
51. Age-dependent changes of p57(Kip2) and p21(Cip1/Waf1) expression in skeletal muscle and lung of mice.
Park CW; Chung JH
Biochim Biophys Acta; 2001 Aug; 1520(2):163-8. PubMed ID: 11513958
[TBL] [Abstract][Full Text] [Related]
52. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer.
Kim YK; Yu J; Han TS; Park SY; Namkoong B; Kim DH; Hur K; Yoo MW; Lee HJ; Yang HK; Kim VN
Nucleic Acids Res; 2009 Apr; 37(5):1672-81. PubMed ID: 19153141
[TBL] [Abstract][Full Text] [Related]
53. Identification of multiple cell cycle regulatory functions of p57Kip2 in human T lymphocytes.
Li G; Domenico J; Lucas JJ; Gelfand EW
J Immunol; 2004 Aug; 173(4):2383-91. PubMed ID: 15294951
[TBL] [Abstract][Full Text] [Related]
54. Significance of p57(Kip2) down-regulation in oncogenesis of bladder carcinoma: an immunohistochemical study.
Bozdoğan O; Atasoy P; Batislam E; Başar MM; Başar H
Tumori; 2008; 94(4):556-62. PubMed ID: 18822693
[TBL] [Abstract][Full Text] [Related]
55. Expression and mutational analysis of Cip/Kip family in early glottic cancer.
Kim DK; Lee JH; Lee OJ; Park CH
J Laryngol Otol; 2015 Feb; 129(2):168-73. PubMed ID: 25695279
[TBL] [Abstract][Full Text] [Related]
56. p57(KIP2) regulates radial glia and intermediate precursor cell cycle dynamics and lower layer neurogenesis in developing cerebral cortex.
Mairet-Coello G; Tury A; Van Buskirk E; Robinson K; Genestine M; DiCicco-Bloom E
Development; 2012 Feb; 139(3):475-87. PubMed ID: 22223678
[TBL] [Abstract][Full Text] [Related]
57. The long non-coding RNA Kcnq1ot1 controls maternal p57 expression in muscle cells by promoting H3K27me3 accumulation to an intragenic MyoD-binding region.
Andresini O; Rossi MN; Matteini F; Petrai S; Santini T; Maione R
Epigenetics Chromatin; 2019 Jan; 12(1):8. PubMed ID: 30651140
[TBL] [Abstract][Full Text] [Related]
58. p57 kip2's role beyond Schwann cell cycle control.
Heinen A; Kremer D; Hartung HP; Küry P
Cell Cycle; 2008 Sep; 7(18):2781-6. PubMed ID: 18769142
[TBL] [Abstract][Full Text] [Related]
59. A cell-autonomous requirement for Cip/Kip cyclin-kinase inhibitors in regulating neuronal cell cycle exit but not differentiation in the developing spinal cord.
Gui H; Li S; Matise MP
Dev Biol; 2007 Jan; 301(1):14-26. PubMed ID: 17123502
[TBL] [Abstract][Full Text] [Related]
60. High Dosage Lithium Treatment Induces DNA Damage and p57
Stampone E; Bencivenga D; Barone C; Aulitto A; Verace F; Della Ragione F; Borriello A
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
